Search research articles
Contact Us
Filters
Showing results (41-50 of 57) with videos related to
Page
of 6
Sort By:
Malaria Journal
|
October 2, 2017
Measuring ex vivo drug susceptibility in Plasmodium vivax isolates from Cambodia
Suwanna Chaorattanakawee, Chanthap Lon, Soklyda Chann, et al.
The American Journal of Tropical Medicine and Hygiene
|
May 13, 2020
Prevalence of CYP2D6 Genotypes and Predicted Phenotypes in a Cohort of Cambodians at High Risk for Infections with <i>Plasmodium vivax</i>
Michele D Spring, Chanthap Lon, Somethy Sok, et al.
The Journal of Infectious Diseases
|
November 28, 2019
Corrigendum to: Determination of Cytochrome P450 Isoenzyme 2D6 (CYP2D6) Genotypes and Pharmacogenomic Impact on Primaquine Metabolism in an Active-Duty US Military Population
Michele D Spring, Jason C Sousa, Qigui Li, et al.
The Journal of Infectious Diseases
|
September 25, 2019
Determination of Cytochrome P450 Isoenzyme 2D6 (CYP2D6) Genotypes and Pharmacogenomic Impact on Primaquine Metabolism in an Active-Duty US Military Population
Michele D Spring, Jason C Sousa, Qigui Li, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
June 6, 2023
The parasite intraerythrocytic cycle and human circadian cycle are coupled during malaria infection
Francis C Motta, Kevin McGoff, Robert C Moseley, et al.
The Journal of Infectious Diseases
|
September 22, 2017
Association of a Novel Mutation in the Plasmodium falciparum Chloroquine Resistance Transporter With Decreased Piperaquine Sensitivity
Sonia Agrawal, Kara A Moser, Lindsay Morton, et al.
Plos Neglected Tropical Diseases
|
February 27, 2016
Phase 1/2a Trial of Plasmodium vivax Malaria Vaccine Candidate VMP001/AS01B in Malaria-Naive Adults: Safety, Immunogenicity, and Efficacy
Jason W Bennett, Anjali Yadava, Donna Tosh, et al.
Malaria Journal
|
January 25, 2013
Results from tandem Phase 1 studies evaluating the safety, reactogenicity and immunogenicity of the vaccine candidate antigen Plasmodium falciparum FVO merozoite surface protein-1 (MSP1(42)) administered intramuscularly with adjuvant system AS01
Nekoye Otsyula, Evelina Angov, Elke Bergmann-Leitner, et al.
Scientific Reports
|
June 29, 2021
Plasmodium falciparum phenotypic and genotypic resistance profile during the emergence of Piperaquine resistance in Northeastern Thailand
Nonlawat Boonyalai, Chatchadaporn Thamnurak, Piyaporn Sai-Ngam, et al.
The Journal of Infectious Diseases
|
February 2, 2021
Distribution and Temporal Dynamics of Plasmodium falciparum Chloroquine Resistance Transporter Mutations Associated With Piperaquine Resistance in Northern Cambodia
Biraj Shrestha, Zalak Shah, Andrew P Morgan, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 57) with videos related to
Sort By:
Page
of 6
Malaria Journal
|
October 2, 2017
Measuring ex vivo drug susceptibility in Plasmodium vivax isolates from Cambodia
Suwanna Chaorattanakawee, Chanthap Lon, Soklyda Chann, et al.
The American Journal of Tropical Medicine and Hygiene
|
May 13, 2020
Prevalence of CYP2D6 Genotypes and Predicted Phenotypes in a Cohort of Cambodians at High Risk for Infections with <i>Plasmodium vivax</i>
Michele D Spring, Chanthap Lon, Somethy Sok, et al.
The Journal of Infectious Diseases
|
November 28, 2019
Corrigendum to: Determination of Cytochrome P450 Isoenzyme 2D6 (CYP2D6) Genotypes and Pharmacogenomic Impact on Primaquine Metabolism in an Active-Duty US Military Population
Michele D Spring, Jason C Sousa, Qigui Li, et al.
The Journal of Infectious Diseases
|
September 25, 2019
Determination of Cytochrome P450 Isoenzyme 2D6 (CYP2D6) Genotypes and Pharmacogenomic Impact on Primaquine Metabolism in an Active-Duty US Military Population
Michele D Spring, Jason C Sousa, Qigui Li, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
June 6, 2023
The parasite intraerythrocytic cycle and human circadian cycle are coupled during malaria infection
Francis C Motta, Kevin McGoff, Robert C Moseley, et al.
The Journal of Infectious Diseases
|
September 22, 2017
Association of a Novel Mutation in the Plasmodium falciparum Chloroquine Resistance Transporter With Decreased Piperaquine Sensitivity
Sonia Agrawal, Kara A Moser, Lindsay Morton, et al.
Plos Neglected Tropical Diseases
|
February 27, 2016
Phase 1/2a Trial of Plasmodium vivax Malaria Vaccine Candidate VMP001/AS01B in Malaria-Naive Adults: Safety, Immunogenicity, and Efficacy
Jason W Bennett, Anjali Yadava, Donna Tosh, et al.
Malaria Journal
|
January 25, 2013
Results from tandem Phase 1 studies evaluating the safety, reactogenicity and immunogenicity of the vaccine candidate antigen Plasmodium falciparum FVO merozoite surface protein-1 (MSP1(42)) administered intramuscularly with adjuvant system AS01
Nekoye Otsyula, Evelina Angov, Elke Bergmann-Leitner, et al.
Scientific Reports
|
June 29, 2021
Plasmodium falciparum phenotypic and genotypic resistance profile during the emergence of Piperaquine resistance in Northeastern Thailand
Nonlawat Boonyalai, Chatchadaporn Thamnurak, Piyaporn Sai-Ngam, et al.
The Journal of Infectious Diseases
|
February 2, 2021
Distribution and Temporal Dynamics of Plasmodium falciparum Chloroquine Resistance Transporter Mutations Associated With Piperaquine Resistance in Northern Cambodia
Biraj Shrestha, Zalak Shah, Andrew P Morgan, et al.
Page
of 6